Baik Kyoungwon, Jeon Seun, Park Mincheol, Lee Young-Gun, Lee Phil Hyu, Sohn Young H, Ye Byoung Seok
Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
Brain Research Institute, Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.
J Clin Neurol. 2023 May;19(3):260-269. doi: 10.3988/jcn.2022.0207. Epub 2023 Feb 3.
To determine the imaging characteristics and cutoff value of F-florapronol (FC119S) quantitative analysis for detecting β-amyloid positivity and Alzheimer's disease (AD), we compared the findings of FC119S and F-florbetaben (FBB) positron-emission tomography (PET) in patients with cognitive impairment.
We prospectively enrolled 35 patients with cognitive impairment who underwent FBB-PET, FC119S-PET, and brain magnetic resonance imaging. We measured global and vertex-wise standardized uptake value ratios (SUVRs) using a surface-based method with the cerebellar gray matter as reference. Optimal global FC119S SUVR cutoffs were determined using receiver operating characteristic curves for β-amyloid positivity based on the global FBB SUVR of 1.478 and presence of AD, respectively. We evaluated the global and vertex-wise SUVR correlations between the two tracers. In addition, we performed correlation analysis for global or vertex-wise SUVR of each tracer with the vertex-wise cortical thicknesses.
The optimal global FC119S SUVR cutoff value was 1.385 both for detecting β-amyloid positivity and for detecting AD. Based on the global SUVR cutoff value of each tracer, 32 (91.4%) patients had concordant β-amyloid positivity. The SUVRs of FC119S and FBB had strong global (=0.72) and vertex-wise (>0.7) correlations in the overall cortices, except for the parietal and temporal cortices (0.4<<0.7). The FC119S SUVR had significant negative vertex-wise correlations with cortical thicknesses in the posterior cingulate, anterior cingulate, parietal, posterior temporal, and occipital cortices.
Quantitative FC119S-PET analysis provided reliable information for detecting β-amyloid deposition and the presence of AD.
为确定F-氟罗普诺(FC119S)定量分析检测β-淀粉样蛋白阳性及阿尔茨海默病(AD)的影像特征和临界值,我们比较了认知障碍患者中FC119S和F-氟贝他班(FBB)正电子发射断层扫描(PET)的结果。
我们前瞻性纳入了35例接受FBB-PET、FC119S-PET及脑磁共振成像检查的认知障碍患者。我们采用以小脑灰质为参照的基于表面的方法测量全脑及各顶点的标准化摄取值比率(SUVR)。分别基于1.478的全脑FBB SUVR及AD的存在情况,使用受试者工作特征曲线确定检测β-淀粉样蛋白阳性的最佳全脑FC119S SUVR临界值。我们评估了两种示踪剂之间全脑及各顶点SUVR的相关性。此外,我们对每种示踪剂的全脑或各顶点SUVR与各顶点皮质厚度进行了相关性分析。
检测β-淀粉样蛋白阳性及检测AD时,最佳全脑FC119S SUVR临界值均为1.385。基于每种示踪剂的全脑SUVR临界值,32例(91.4%)患者的β-淀粉样蛋白阳性情况一致。除顶叶和颞叶皮质(0.4<相关性<0.7)外,FC119S和FBB的SUVR在整个皮质中具有较强的全脑相关性(=0.72)及各顶点相关性(>0.7)。FC119S SUVR与后扣带回、前扣带回、顶叶、颞叶后部及枕叶皮质的皮质厚度具有显著的顶点负相关性。
定量FC119S-PET分析为检测β-淀粉样蛋白沉积及AD的存在提供了可靠信息。